30 phenotypes from 3 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sgcdtm1Kcam/Sgcdtm1Kcam involves: 129S1/Sv * 129X1/SvJ	abnormal cardiovascular system physiology	J:57107
	abnormal heart morphology	J:57107
	cardiac fibrosis	J:57107
	cardiomyopathy	J:57107
	coronary artery stenosis	J:57107
	decreased QRS amplitude	J:57107
	dilated cardiomyopathy	J:57107
	dilated heart ventricle	J:57107
	dystrophic cardiac calcinosis	J:57107
	dystrophic muscle	J:57107
	increased susceptibility to induced morbidity/mortality	J:57107
	myocardium necrosis	J:57107
	premature death	J:57107
	skeletal muscle necrosis	J:57107
Sgcdtm1Mcn/Sgcdtm1Mcn B6.129-Sgcdtm1Mcn/J	abnormal muscle physiology	J:250485
	abnormal skeletal muscle morphology	J:250485
	cardiac fibrosis	J:234761, J:250485
	cardiac muscle degeneration	J:234761
	cardiac muscle necrosis	J:234761
	decreased cardiac muscle contractility	J:234761
	decreased grip strength	J:250485
	decreased pulmonary respiratory rate	J:250485
	dilated cardiomyopathy	J:234761
	dystrophic muscle	J:250485
	increased circulating creatine kinase level	J:250485
	skeletal muscle fibrosis	J:250485
Sgcdtm1Mcn/Sgcdtm1Mcn involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ	abnormal muscle contractility	J:76730
	abnormal muscle physiology	J:76730
	cardiomyopathy	J:76730
	dystrophic muscle	J:76730
	increased circulating creatine kinase level	J:76730
	muscle degeneration	J:76730
	perivascular fibrosis	J:76730
	premature death	J:76730
Sgcdtm1Ojml/Sgcd+ B6.129-Sgcdtm1Ojml	abnormal response to exercise	J:234761
	decreased aerobic running capacity	J:234761
	dilated cardiomyopathy	J:234761
	increased heart weight	J:234761
Sgcdtm1Ojml/Sgcdtm1Ojml B6.129-Sgcdtm1Ojml	prenatal lethality, complete penetrance	J:234761